FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 312:1293-1296 May 16, 1985 Number 20 Next

	Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

Abstract

To investigate whether infection with human T-cell lymphotropic virus/lymphadenopathy-associated virus (HTLV-III/LAV) may be persistent in asymptomatic persons and to correlate infection with seropositivity, we performed virologic and serologic studies in 25 of 30 persons who were identified as being at high risk for the acquired immunodeficiency syndrome (AIDS) and who had donated blood to patients who later contracted transfusion-associated AIDS. High-risk donors were those who belonged to a high-risk population, had AIDS or a closely related condition, or had a low ratio of helper to suppressor T lymphocytes. We performed similar studies in 6 of the 24 patients with AIDS who had received donations from this group. HTLV-III/LAV was isolated from 22 of the 25 donors, between 12 and 52 months (mean, 28) after they had donated blood, and from all 6 recipients, between 14 and 37 months (mean, 26) after they had received blood. Of the 22 virus-positive donors, 2 have contracted AIDS, 5 have generalized lymphadenopathy, and 15 (68 per cent) remain asymptomatic. Antibodies to HTLV-III/LAV were detectable by the enzyme-linked immunosorbent assay in serum samples obtained from each person at the time the virus was isolated. We conclude that infection with HTLV-III/LAV may be persistent and asymptomatic for years. This demonstration that viremic patients may be asymptomatic supports the use of serologic screening of donated blood to supplement current procedures for the prevention of transfusion-associated AIDS.

This article has been cited by other articles:

• Nelson, R. P. Jr, Price, L. J., Halsey, A. B., Graven, S. N., Resnick, L., Day, N. K., Lockey, R. F., Good, R. A. (1996). Diagnosis of Pediatric Human Immunodeficiency Virus Infection by Means of a Commercially Available Polymerase Chain Reaction Gene Amplification. Arch Pediatr Adolesc Med 150: 40-45 [Abstract]  
• King, S. M., Murphy, T., Corey, M., Newman, A. M., Major, C., McCrindle, B. W., Irwin, J., Stevens, M., Fearon, M., Poon, A. O. (1995). The HIV Information Project for Transfusion Recipients a Decade After Transfusion. Arch Pediatr Adolesc Med 149: 680-685 [Abstract]  
• Schwartz, J. S., Kinosian, B. P., Pierskalla, W. P., Lee, H. (1990). Strategies for Screening Blood for Human Immunodeficiency Virus Antibody: Use of a Decision Support System. JAMA 264: 1704-1710 [Abstract]  
• Haverkos, H. W., Edelman, R. (1988). The Epidemiology of Acquired Immunodeficiency Syndrome Among Heterosexuals. JAMA 260: 1922-1929 [Abstract]  
• Koff, W., Hoth, D. (1988). Development and testing of AIDS vaccines. Science 241: 426-432 [Abstract]  
• Ou, C., Kwok, S, Mitchell, S., Mack, D., Sninsky, J., Krebs, J., Feorino, P, Warfield, D, Schochetman, G (1988). DNA amplification for direct detection of HIV-1 in DNA of peripheral blood mononuclear cells. Science 239: 295-297 [Abstract]  
• Mariner, W. K., Gallo, R. C. (1987). Getting to Market: The Scientific and Legal Climate for Developing an AIDS Vaccine. J Law Med Ethics 15: 17-26  
• WARD, J. W., DEPPE, D. A., SAMSON, S., PERKINS, H., HOLLAND, P., FERNANDO, L., FEORINO, P. M., THOMPSON, P., KLEINMAN, S., ALLEN, J. R. (1987). Risk of Human Immunodeficiency Virus Infection from Blood Donors Who Later Developed the Acquired Immunodeficiency Syndrome. ANN INTERN MED 106: 61-62 [Abstract]  
• MARMOR, M., WEISS, L. R., LYDEN, M., WEISS, S. H., SAXINGER, W. C., SPIRA, T. J., FEORINO, P. M. (1986). Possible Female-to-Female Transmission of Human Immunodeficiency Virus. ANN INTERN MED 105: 969-969 [Abstract]  
• CONTE, J. E. Jr. (1986). Infection with Human Immunodeficiency Virus in the Hospital: Epidemiology, Infection Control, and Biosafety Considerations. ANN INTERN MED 105: 730-736 [Abstract]  
• Peterman, T. A., Curran, J. W. (1986). Sexual Transmission of Human Immunodeficiency Virus. JAMA 256: 2222-2226 [Abstract]  
• ANDERSON, K. C., GORGONE, B. C., MARLINK, R. G., FERRIANI, R., ESSEX, M. E., BENZ, P. M., GROOPMAN, J. E. (1986). Transfusion-Acquired Human Immunodeficiency Virus Infection Among Immunocompromised Persons. ANN INTERN MED 105: 519-527 [Abstract]  
• WOOD, C. C., WILLIAMS, A. E., McNAMARA, J. G., ANNUNZIATA, J. A., FEORINO, P. M., CONWAY, C. O. (1986). Antibody Against the Human Immunodeficiency Virus in Commercial Intravenous Gammaglobulin Preparations. ANN INTERN MED 105: 536-538 [Abstract]  
• PERRILLO, R. P., REGENSTEIN, F. G., ROODMAN, S. T. (1986). Chronic Hepatitis B in Asymptomatic Homosexual Men with Antibody to the Human Immunodeficiency Virus. ANN INTERN MED 105: 382-383 [Abstract]  
• Francis, D. P., Feorino, P. M., McDougal, S., Warfield, D., Getchell, J., Cabradilla, C., Tong, M., Miller, W. J., Schultz, L. D., Bailey, F. J., McAleer, W. J., Scolnick, E. M., Ellis, R. W. (1986). The Safety of the Hepatitis B Vaccine: Inactivation of the AIDS Virus During Routine Vaccine Manufacture. JAMA 256: 869-872 [Abstract]  
• Ward, J. W., Grindon, A. J., Feorino, P. M., Schable, C., Parvin, M., Allen, J. R. (1986). Laboratory and Epidemiologic Evaluation of an Enzyme Immunoassay for Antibodies to HTLV-III. JAMA 256: 357-361 [Abstract]  
• MORRISON, A. J. Jr., FREER, C. V., POOLE, C. L., JOHNSTON, D. O., WESTERVELT, F. Jr., NORMANSELL, D. E., WENZEL, R. P. (1986). Prevalence of Human T-Lymphotropic Virus Type III Antibodies Among Patients in Dialysis Programs at a University Hospital. ANN INTERN MED 104: 805-807 [Abstract]  
• (1986). Leads from the MMWR. JAMA 255: 25-31  
• Peterman, T. A., Jaffe, H. W., Feorino, P. M., Getchell, J. P., Warfield, D. T., Haverkos, H. W., Stoneburner, R. L., Curran, J. W. (1985). Transfusion-Associated Acquired Immunodeficiency Syndrome in the United States. JAMA 254: 2913-2917 [Abstract]  
• CURRAN, J. W. (1985). The Epidemiology and Prevention of the Acquired Immunodeficiency Syndrome. ANN INTERN MED 103: 657-662 [Abstract]  
• BLATTNER, W. A., BIGGAR, R. J., WEISS, S. H., MELBYE, M., GOEDERT, J. J. (1985). Epidemiology of Human T-Lymphotropic Virus Type III and the Risk of the Acquired Immunodeficiency Syndrome. ANN INTERN MED 103: 665-670 [Abstract]  
• FRANCIS, D. P., JAFFE, H. W., FULTZ, P. N., GETCHELL, J. P., McDOUGAL, J. S., FEORINO, P. M. (1985). The Natural History of Infection with the Lymphadenopathy-Associated Virus Human T-Lymphotropic Virus Type III. ANN INTERN MED 103: 719-722 [Abstract]  
• Curran, J., Morgan, W., Hardy, A., Jaffe, H., Darrow, W., Dowdle, W. (1985). The epidemiology of AIDS: current status and future prospects. Science 229: 1352-1357 [Abstract]  
• (1985). Leads from the MMWR. JAMA 254: 1134-1143  
• Dienstag, J. L., Werner, B. G., McLane, M. F., Snydman, D. R., Grady, G. F., Craven, D. E., Crumpacker, C. S., Polk, B. F., Platt, R., Allan, J., Essex, M. (1985). Absence of Antibodies to HTLV-III in Health Workers After Hepatitis B Vaccination. JAMA 254: 1064-1066 [Abstract]